Not all radiologists adhere to practice guidelines that direct providers how to respond to the presence of pulmonary nodules.
A follow-up recommendation from a radiologist in response to a pulmonary nodule is not necessarily guaranteed. A new study shows there is widespread variation in whether providers make this call.
In a new study published Feb. 7 in the Journal of the American College of Radiology, investigators from Brigham and Women’s Hospital showed that radiologists do not always follow the practice guidelines that are intended to instruct them on how to respond when they detect pulmonary nodules.
“Unwarranted variation for pulmonary nodules could have significant downstream implication on not only frequency of repeat imaging, but overall medical costs and quality of patient care,” wrote the team led by Neena Kapoor, M.D., quality of patient safety officer with Brigham and Women’s radiology department. “How to alter radiologist behavior and reduce variation in reporting of follow-up recommendations is a challenging problem that likely requires multiple interventions and stake holder engagement.”
In reaching this conclusion, Kapoor’s team examined 142,001 chest and abdominal reports from its abdominal, thoracic, and emergency radiology sub-specialty divisions between Jan. 1, 2016, to Dec. 31, 2018. Using natural language processing, they identified 24,512 pulmonary nodule reports that did not end with a lung cancer diagnosis.
Among the reports they analyzed, 20 percent – 4,939 reports – included follow-up recommendations for pulmonary nodules. These reports came mainly from chest CTs (76 percent) and outpatient environments (63 percent), and thoracic radiologists assessed nearly two-thirds (64 percent).
According to their investigation, the team found that male patients and abdominal CTs were less likely to have a follow-up recommendation for a pulmonary nodule. However, older patients had higher rates of follow-up recommendations. In addition, inpatient and emergency department exams, as well as exams where a trainee is present, are more likely to result in a recommendation.
All told, the team said, they identified a 4.3-fold difference between radiologists in the probability that they would make a pulmonary nodule follow-up recommendation. However, they stopped short of drilling down on why these differences exist.
“Our work serves as a first step for future work to quantify the magnitude of variability in follow-up recommendations for pulmonary nodules,” they said. “Further studies will need to determine the downstream implications of variation in follow-up recommendations, including the clinical appropriateness of radiologist recommendations, variability in length of follow-up or imaging modalities used, and downstream imaging costs and quality of care.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.